Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatocellular carcinoma].

I B Andersen, T I Sørensen, K Krogsgaard

    Ugeskrift for Laeger
    |February 27, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Hepatocellular carcinoma (HCC) is a serious cancer with increasing global incidence. While generally having a poor prognosis, a specific variant, fibrolamellar hepatocarcinoma, shows a significantly better one-year survival rate.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): Immune responses to Vacc-4x regions on p24 and changes in HIV reservoirs.

    The Journal of infection·2017
    Same author

    Exercise program for prevention of groin pain in football players: a cluster-randomized trial.

    Scandinavian journal of medicine & science in sports·2009
    Same author

    WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C.

    The Cochrane database of systematic reviews·2007
    Same author

    Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.

    The Cochrane database of systematic reviews·2005
    Same author

    Intake of wine, beer and spirits and risk of gastric cancer.

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2005
    Same author

    Glucocorticosteroids for viral hepatitis C.

    The Cochrane database of systematic reviews·2004
    Same journal

    [Mosaicism as a cause of Cowden syndrome].

    Ugeskrift for laeger·2026
    Same journal

    [Thyrotoxic crisis with cardiogenic shock].

    Ugeskrift for laeger·2026
    Same journal

    [Mindfulness-based cognitive therapy in the treatment of depression].

    Ugeskrift for laeger·2026
    Same journal

    [Fitness].

    Ugeskrift for laeger·2026
    Same journal

    [Risk of developing cataract related to fluoroscopy].

    Ugeskrift for laeger·2026
    Same journal

    [Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

    Ugeskrift for laeger·2026
    See all related articles

    Area of Science:

    • Hepatology and Oncology
    • Cancer Etiology and Epidemiology

    Context:

    • Hepatocellular carcinoma (HCC) represents 1% of cancer cases in Denmark, with a rising global incidence.
    • HCC is characterized by high malignancy and a poor average survival rate of six months post-diagnosis.
    • Fibrolamellar hepatocarcinoma, a histological variant, demonstrates a markedly improved one-year survival rate of 75%.

    Purpose:

    • To summarize the key epidemiological, etiological, and therapeutic aspects of Hepatocellular Carcinoma (HCC).
    • To highlight the prognostic differences between typical HCC and its fibrolamellar variant.

    Summary:

    • HCC has a multifactorial etiology, with Hepatitis B virus, cirrhosis, and aflatoxin being primary risk factors, potentiated by alcohol.
    • Current therapeutic options for HCC are limited and primarily palliative.

    Related Experiment Videos

  • Liver resection and transplantation are viable in select HCC cases.

    • Impact:

    • Understanding HCC's diverse etiology and prognosis is crucial for targeted research and clinical management.
    • Identifying prognostic indicators, like the fibrolamellar variant's survival rate, can inform patient counseling and treatment strategies.
    • This overview underscores the need for improved therapeutic interventions for Hepatocellular Carcinoma.